210 related articles for article (PubMed ID: 3424077)
1. [Rectal shielding for a Selectron-ring applicator system (HDR- and LDR-afterloading)].
Hetzel H; Kamleitner H; McCoy M; Frommhold H
Strahlenther Onkol; 1987 Dec; 163(12):782-6. PubMed ID: 3424077
[TBL] [Abstract][Full Text] [Related]
2. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
3. [Simplified HDR-afterloading and high-voltage therapy of cervical carcinoma].
Hetzel H; Fritsch E; Url M; Frommhold H; Dapunt O
Strahlenther Onkol; 1987 Dec; 163(12):774-81. PubMed ID: 3122347
[TBL] [Abstract][Full Text] [Related]
4. Screens in ovoids of a Selectron cervix applicator.
Meertens H; van der Laarse R
Radiother Oncol; 1985 Jan; 3(1):69-80. PubMed ID: 3975442
[TBL] [Abstract][Full Text] [Related]
5. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
6. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
7. Rectum dose analysis employing a multi-purpose brachytherapy phantom.
Huh H; Kim W; Loh JJ; Lee S; Kim CY; Lee S; Shin D; Shin D; Cho S; Jang J; Lim S; Cho KH; Kwon S; Kim S
Jpn J Clin Oncol; 2007 May; 37(5):391-8. PubMed ID: 17538010
[TBL] [Abstract][Full Text] [Related]
8. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
9. [The new development of an afterloading applicator for the primary treatment of endometrial carcinoma. The first clinical empirical report].
Bauer M; Schulz-Wendtland R; van t' Hooft E; Richard F
Strahlenther Onkol; 1991 Sep; 167(9):545-8. PubMed ID: 1925938
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of rectal shielding in a Henschke system applicator.
Howlett SJ; Denham JW; Kron T
Strahlenther Onkol; 1996 May; 172(5):265-9. PubMed ID: 8633259
[TBL] [Abstract][Full Text] [Related]
11. An analysis of the effect of ovoid shields in a selectron-LDR cervical applicator on dose distributions in rectum and bladder.
Steggerda MJ; Moonen LM; Damen EM; Lebesque JV
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):237-45. PubMed ID: 9300759
[TBL] [Abstract][Full Text] [Related]
12. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
[TBL] [Abstract][Full Text] [Related]
13. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
14. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry.
Tanderup K; Christensen JJ; Granfeldt J; Lindegaard JC
Radiother Oncol; 2006 Apr; 79(1):87-93. PubMed ID: 16546281
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
[TBL] [Abstract][Full Text] [Related]
16. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract][Full Text] [Related]
17. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading.
Brooks S; Bownes P; Lowe G; Bryant L; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):934-9. PubMed ID: 16199322
[TBL] [Abstract][Full Text] [Related]
18. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
[TBL] [Abstract][Full Text] [Related]
20. [The value of NMR tomography in the planning of HDR-afterloading brachytherapy in cervical carcinomas. The experiences with 41 patients].
Schmidt BF; Hirnle P; Kaulich TW; Skalej M; Bamberg M
Rofo; 1991 Aug; 155(2):109-16. PubMed ID: 1878536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
